- Home
- LLYVK vs INSP Comparison
LLYVK vs INSP Comparison
Compare LLYVK & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LLYVK
- INSP
- Stock Information
- Founded
- LLYVK 1991
- INSP 2007
- Country
- LLYVK United States
- INSP United States
- Employees
- LLYVK N/A
- INSP N/A
- Industry
- LLYVK Broadcasting
- INSP Medical/Dental Instruments
- Sector
- LLYVK Industrials
- INSP Health Care
- Exchange
- LLYVK Nasdaq
- INSP Nasdaq
- Market Cap
- LLYVK 4.8B
- INSP 5.3B
- IPO Year
- LLYVK N/A
- INSP 2018
- Fundamental
- Price
- LLYVK $71.31
- INSP $186.06
- Analyst Decision
- LLYVK
- INSP Buy
- Analyst Count
- LLYVK 0
- INSP 11
- Target Price
- LLYVK N/A
- INSP $232.55
- AVG Volume (30 Days)
- LLYVK 536.5K
- INSP 582.0K
- Earning Date
- LLYVK 01-01-0001
- INSP 11-04-2024
- Dividend Yield
- LLYVK N/A
- INSP N/A
- EPS Growth
- LLYVK N/A
- INSP N/A
- EPS
- LLYVK N/A
- INSP 1.09
- Revenue
- LLYVK N/A
- INSP $755,594,000.00
- Revenue This Year
- LLYVK N/A
- INSP $29.96
- Revenue Next Year
- LLYVK $9.30
- INSP $19.42
- P/E Ratio
- LLYVK N/A
- INSP $170.11
- Revenue Growth
- LLYVK N/A
- INSP 32.52
- 52 Week Low
- LLYVK $32.49
- INSP $123.00
- 52 Week High
- LLYVK $71.53
- INSP $257.40
- Technical
- Relative Strength Index (RSI)
- LLYVK 82.56
- INSP 46.09
- Support Level
- LLYVK $64.02
- INSP $170.23
- Resistance Level
- LLYVK $69.07
- INSP $191.52
- Average True Range (ATR)
- LLYVK 2.29
- INSP 10.24
- MACD
- LLYVK 0.45
- INSP -0.94
- Stochastic Oscillator
- LLYVK 97.42
- INSP 36.03
About LLYVK Liberty Media Corporation Series C Liberty Live
Liberty Live Group would be engaged in the operations of Live Nation, and Liberty Media's strategy for that group is to maximize the value of its investment in that company and the other assets attributed to the Liberty Live Group and to use the new Liberty Live common stock to make strategic acquisitions or for other capital raising initiatives.
About INSP Inspire Medical Systems Inc.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.